# BZYR (Burzynski Research Institute Inc.) - SEC EDGAR Financial Statements

> Burzynski Research Institute Inc. reported $0 in revenue and a net loss of $1.29M for the trailing twelve months ended November 30, 2025.

- Canonical: https://convexityos.com/fundamentals/BZYR
- Markdown: https://convexityos.com/fundamentals/BZYR.md
- SEC CIK: 0000724445
- Reporting currency: USD
- Latest filing period: November 30, 2025
- Last synced: Nov 21, 2026, 05:16 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000724445&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $0 | Nov 30, 2025 |
| Operating Income | TTM | -$1.29M | Operating profit |
| Net Income | TTM | -$1.29M | GAAP bottom line |
| Diluted EPS | TTM | -$0.01 | Split-adjusted |
| Free Cash Flow | TTM | -- | Operating CF less CapEx |
| Cash & ST Investments | Nov 30, 2025 | $2.2K | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Research & Development | $1.05M | $865K | $719K | $760K | $1.02M | $1.20M | $1.15M | $1.28M | $1.32M | $1.85M |
| Total Operating Expenses | $1.39M | $1.34M | $916K | $977K | $1.30M | $1.63M | $1.64M | $1.61M | $1.50M | $2.01M |
| **Operating Income** | -$1.39M | -$1.34M | -$916K | -$977K | -$1.30M | -$1.63M | -$1.64M | -$1.61M | -$1.50M | -$2.01M |
| **EBITDA** | -- | -- | -- | -- | -- | -- | -- | -$1.61M | -$1.50M | -$2.00M |
| Income Before Tax | -$1.39M | -$1.34M | -$916K | -$977K | -$1.20M | -$1.63M | -$1.64M | -$1.61M | -$1.50M | -$2.01M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | -- | -- | -- | $0 |
| **Net Income** | -$1.39M | -$1.34M | -$916K | -$977K | -$1.20M | -$1.63M | -$1.64M | -$1.61M | -$1.50M | -$2.01M |
| Basic EPS | -$0.01 | -$0.01 | -$0.01 | -$0.01 | -$0.01 | -$0.01 | -$0.01 | -$0.01 | -$0.01 | -$0.02 |
| **Diluted EPS** | -$0.01 | -$0.01 | -$0.01 | -$0.01 | -$0.01 | -$0.01 | -$0.01 | -$0.01 | -$0.01 | -$0.02 |
| Basic Shares Outstanding | 131.4M | 131.4M | 131.4M | 131.4M | 131.4M | 131.4M | 131.4M | 131.4M | 131.4M | 131.4M |
| Diluted Shares Outstanding | 131.4M | 131.4M | 131.4M | 131.4M | 131.4M | 131.4M | 131.4M | 131.4M | 131.4M | 131.4M |

### Income Statement (Quarterly)

| Line Item | Nov 2025 | Aug 2025 | May 2025 | Feb 2025 | Nov 2024 | Aug 2024 | May 2024 | Feb 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Research & Development | $261K | $255K | $270K | $241K | $301K | $277K | $226K | $251K |
| Total Operating Expenses | $329K | $334K | $331K | $293K | $352K | $370K | $371K | $363K |
| **Operating Income** | -$329K | -$334K | -$331K | -$293K | -$352K | -$370K | -$371K | -$363K |
| Income Before Tax | -$329K | -$334K | -$331K | -$293K | -$352K | -$370K | -$371K | -$363K |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$329K | -$334K | -$331K | -$293K | -$352K | -$370K | -$371K | -$363K |
| Basic EPS | $0.00 | $0.00 | $0.00 | -- | $0.00 | $0.00 | $0.00 | -- |
| **Diluted EPS** | $0.00 | $0.00 | $0.00 | -- | $0.00 | $0.00 | $0.00 | -- |
| Basic Shares Outstanding | 131.4M | 131.4M | 131.4M | -- | 131.4M | 131.4M | 131.4M | -- |
| Diluted Shares Outstanding | 131.4M | 131.4M | 131.4M | -- | 131.4M | 131.4M | 131.4M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $847 | $1.3K | $934 | $3.4K | $62 | $163 | $708 | $506 | $731 | $3.3K |
| **Cash & Short-Term Investments** | $847 | $1.3K | $934 | $3.4K | $62 | $163 | $708 | $506 | $731 | $3.3K |
| **Total Current Assets** | $847 | $2.3K | $1.9K | $4.7K | $956 | $20K | $22K | $29K | $11K | $3.3K |
| Property, Plant & Equipment, Net | -- | -- | -- | -- | -- | -- | -- | -- | -- | $684 |
| **Total Non-Current Assets** | $0 | $0 | $0 | $0 | $0 | $0 | -$99 | $0 | $0 | $684 |
| **Total Assets** | $847 | $2.3K | $1.9K | $4.7K | $956 | $20K | $22K | $29K | $11K | $4.0K |
| Accounts Payable | $17K | $9.0K | $13K | -- | $33K | $61K | $101K | $42K | $20K | $64K |
| **Total Current Liabilities** | -- | -- | -- | -- | $47K | $172K | $209K | $137K | $44K | $105K |
| **Total Non-Current Liabilities** | -- | -- | -- | -- | $0 | $0 | $0 | $0 | $0 | $0 |
| **Total Liabilities** | $42K | $27K | $16K | $3.5K | $47K | $172K | $209K | $137K | $44K | $105K |
| Common Stock | $131K | $131K | $131K | $131K | $131K | $131K | $131K | $131K | $131K | $131K |
| Retained Earnings | -$129.5M | -$128.1M | -$126.8M | -$125.8M | -$124.9M | -$123.7M | -$122.0M | -$120.4M | -$118.8M | -$117.3M |
| **Total Stockholders' Equity** | -$42K | -$25K | -$14K | $1.2K | -$46K | -$153K | -$187K | -$108K | -$33K | -$101K |
| Total Equity | -$42K | -$25K | -$14K | $1.2K | -$46K | -$153K | -$187K | -$108K | -$33K | -$101K |

### Balance Sheet (Quarterly)

| Line Item | Nov 2025 | Aug 2025 | May 2025 | Feb 2025 | Nov 2024 | Aug 2024 | May 2024 | Feb 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $2.2K | $931 | $821 | $847 | $613 | $1.2K | $297 | $1.3K |
| **Cash & Short-Term Investments** | $2.2K | $931 | $821 | $847 | $613 | $1.2K | $297 | $1.3K |
| **Total Current Assets** | $2.3K | $1.3K | $1.5K | $847 | $713 | $1.6K | $997 | $2.3K |
| **Total Non-Current Assets** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Total Assets** | $2.3K | $1.3K | $1.5K | $847 | $713 | $1.6K | $997 | $2.3K |
| Accounts Payable | $45K | $24K | $26K | $17K | $18K | $77K | $71K | $9.0K |
| **Total Liabilities** | $70K | $71K | $71K | $42K | $22K | $89K | $129K | $27K |
| Common Stock | $131K | $131K | $131K | $131K | $131K | $131K | $131K | $131K |
| Retained Earnings | -$130.5M | -$130.1M | -$129.8M | -$129.5M | -$129.2M | -$128.8M | -$128.5M | -$128.1M |
| **Total Stockholders' Equity** | -$67K | -$70K | -$70K | -$42K | -$21K | -$88K | -$128K | -$25K |
| Total Equity | -$67K | -$70K | -$70K | -$42K | -$21K | -$88K | -$128K | -$25K |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$1.39M | -$1.34M | -$916K | -- | -- | -- | -- | -- | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- | -- | -- | $0 | $684 | $684 |
| Change in Payables | $8.0K | -$3.6K | $13K | -$33K | -$28K | -$40K | $59K | $22K | -$45K | -$36K |
| **Operating Cash Flow** | -$389K | -$524K | -$250K | -$325K | -$394K | -$530K | -$478K | -$319K | -$315K | -$251K |
| **Financing Cash Flow** | $388K | $524K | $247K | $328K | $394K | $530K | $478K | $319K | $312K | $252K |
| **Net Change in Cash** | -$463 | $376 | -$2.4K | $3.3K | -$101 | -$545 | $202 | -$225 | -- | -- |

### Cash Flow Statement (Quarterly)

| Line Item | Nov 2025 | Aug 2025 | May 2025 | Feb 2025 | Nov 2024 | Aug 2024 | May 2024 | Feb 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$329K | -$334K | -$331K | -$293K | -$352K | -$370K | -$371K | -$363K |
| Change in Payables | $21K | -$1.7K | $8.7K | -$764 | -$60K | $6.7K | $62K | -$11K |
| **Operating Cash Flow** | -$823K | -$95K | -$49K | $709K | -$890K | -$148K | -$60K | -$138K |
| **Financing Cash Flow** | $824K | $95K | $49K | -$709K | $890K | $149K | $59K | $138K |
| **Net Change in Cash** | $1.2K | $110 | -$26 | $234 | -$603 | $919 | -$1.0K | $397 |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -- | -- | -- | -80983.1% | -- | -- | -- | -- | -- | -- |
| Return on Assets (ROA) | -163660.8% | -57810.9% | -47378.1% | -20953.8% | -125941.2% | -8232.9% | -7386.4% | -5572.6% | -14022.2% | -50290.9% |
| Current Ratio | -- | -- | -- | -- | 0.02x | 0.12x | 0.11x | 0.21x | 0.25x | 0.03x |
| Quick Ratio | -- | -- | -- | -- | 0.00x | 0.00x | 0.00x | 0.00x | 0.02x | 0.03x |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Nov 2025 | Aug 2025 | May 2025 | Feb 2025 | Nov 2024 | Aug 2024 | May 2024 | Feb 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Assets (ROA) | -56820.2% | -98448.9% | -88515.8% | -163660.8% | -204251.9% | -95117.1% | -142362.9% | -57810.9% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
